ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Zilong Bai

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Unveiling the therapeutic potential of senescence-related IQGAP2 in pancreatic Cancer through post-GWAS genomic and scRNA-seq analyses. Co-author DOI 10.1007/s12672-025-03078-x ↗
Prognostic utility of TME-associated genes in pancreatic cancer. Co-author DOI 10.3389/fgene.2023.1218774 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dongmin Chang · 2 shared papers, 2023–2025 · strength 0.51
- Paper Unveiling the therapeutic potential of senescence-related IQGAP2 in pancreatic Cancer through post-GWAS genomic and scR… DOI 10.1007/s12672-025-03078-x ↗
- Paper Prognostic utility of TME-associated genes in pancreatic cancer. DOI 10.3389/fgene.2023.1218774 ↗
Yuanhua Nie · 2 shared papers, 2023–2025 · strength 0.51
- Paper Unveiling the therapeutic potential of senescence-related IQGAP2 in pancreatic Cancer through post-GWAS genomic and scR… DOI 10.1007/s12672-025-03078-x ↗
- Paper Prognostic utility of TME-associated genes in pancreatic cancer. DOI 10.3389/fgene.2023.1218774 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.